Phathom Pharmaceuticals Inc
General ticker "PHAT" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $554.2M
Phathom Pharmaceuticals Inc follows the US Stock Market performance with the rate: 32.1%.
Estimated limits based on current volatility of 3.5%: low 7.40$, high 7.94$
Factors to consider:
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [4.80$, 11.51$]
- 2024-12-30 to 2025-12-30 estimated range: [3.93$, 9.54$]
Financial Metrics affecting the PHAT estimates:
- Negative: Non-GAAP EPS, $ of -3.29 <= 0.10
- Negative: Operating profit margin, % of -99.59 <= 1.03
- Negative: Operating cash flow per share per price, % of -24.61 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85
- Negative: Industry earnings per price (median), % of -15.01 <= 1.31
Short-term PHAT quotes
Long-term PHAT plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.68MM |
| Operating Expenses | $135.08MM | $172.44MM | $167.99MM |
| Operating Income | $-135.08MM | $-172.44MM | $-167.31MM |
| Non-Operating Income | $-8.80MM | $-25.28MM | $-34.28MM |
| Interest Expense | $6.79MM | $27.30MM | $41.97MM |
| R&D Expense | $72.34MM | $71.44MM | $49.90MM |
| Income(Loss) | $-143.88MM | $-197.72MM | $-201.59MM |
| Profit(Loss) | $-143.88MM | $-197.72MM | $-201.59MM |
| Stockholders Equity | $72.16MM | $-74.81MM | $-72.76MM |
| Inventory | $0.00MM | $0.00MM | $1.21MM |
| Assets | $189.43MM | $164.81MM | $413.84MM |
| Operating Cash Flow | $-148.46MM | $-146.53MM | $-137.58MM |
| Capital expenditure | $0.33MM | $1.04MM | $1.63MM |
| Investing Cash Flow | $-0.33MM | $-1.04MM | $-1.63MM |
| Financing Cash Flow | $44.71MM | $120.04MM | $367.58MM |
| Earnings Per Share* | $-4.00 | $-5.70 | $-3.93 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.